Location:Hotel Albuquerque at Old Town
Albuquerque NM 87104

Time:April 21-25

Dr. JP couderc will present the Center for Quantitative Electrocardiography and Cardiac Safety during an afternoon session.

Location: Park City, Utah

 

 

Time: September 13-16th September

NHLBI award is annouced by Dr. JP couderc during the Session on QT interval technologies. Computers in Cardiology website is available here..

click here to download the slides of the presentation.

Location: Hyatt Regency Bethesda, Bethesda, MD, USA

Time: Thursday 30th 5:00 to 6:00PM

THEW Update will be presented during the session chaired by Dr. Norman Stockbridge entitled Regulatory and Consortium Update.

click here to download the Meeting Agenda in pdf format.

10th Annual Phase I Clinical Trials Conference

Mon 09 Feb 2009 - Thu 12 Feb 2009 Olympia Conference Centre, London, United Kingdom.

Dr. Adel Nada, Medical Director Clinical Pharmacology & Pharmacometrics
from Abbott Labs introduces the THEW initiative in his presentation entitled :"Managing Ventricular Arrhythmia in First-in-Man (FIM) Studies"

Integrating Pre-Clinical & Clinical Issues in Cardiac Safety: Translational Medicine Meets the Critical Path October 6th-7th
Bethesda, Maryland

Presenter: JP Couderc, PhD

“Computerized Method to Detect the QT Prolongation Induced by Moxifloxacin: Reporting the Results From Five-Drug-Safety Trials from the FDA Digital ECG Repository”

DIA – 3rd Annual Cardiac Safety Conference scheduled for December 4 – 5, 2008 taking place at the Hotel Hilton Barcelona in Spain.

December 4, 2008 from 11.00 – 12.30 CET

Session name: “Computerised Methodologies to Asses Cardiac Arrhythmia Vulnerability”. Chair: Boaz Mendezelevski, MD, Cardiac Safety Consultant, Cardiac Safety Consultants Ltd., UK.

Presenter: JP Couderc, PhD

Presentation of the THEW Initiative to the ESGCO Members.

The European Study Group on Cardiovascular Oscillations (ESGCO) was created during an Educational Training Course of the European Society of Cardiology in 1998 by Alberto Malliani, Tudor Griffith, Pontus Persson and Bernard Swynghedauw.
The goal of the Study Group is to promote basic research on cardiovascular oscillations, including heart rate and blood pressure variations, contractility changes, oscillations in microcirculation, calcium waves and ion movements.

Location: Parma , Italy

Presenter: JP Couderc, PhD

Presentation of the THEW project and the recent progress related to its implementation.

Location Miami, FL

The Telemetric and Holter Warehouse Project: - JP Couderc (URMC)

[12/16/2009]: The Director of the THEW interviewed by Technology Review published by the MIT: here.

[11/11/2009]: New Research Center to Focus on Cardiac Safety and Innovation in Pharmaceutical Industry Today: here.

[6/11/2009]: University of of Rochester and FDA Partner for ECG Database, Drug Discovery & Development Magazine. More info here

[5/6/2009] FDA website Existing Partnerships FDA’s Public-Private Partnership Program: THEW

[03/28/2009] Public and Private part- nership to help determine Clinical Biomarker Utility in Applied Clinical Trials online.com.>here

[1/13/2010] Members: The Oxford University Computing Laboratory is the first new member for year 2010. At the heart of computing and related interdisciplinary activity at Oxford, this centre focuses on research in computer science, numerical analysis, computational biology, quantum computation, computational linguistics, and information systems. The Computational Biology Group also plays a key role in interdisciplinary initiatives across the University, including the EU FP7 projects euHeart and PreDiCT.

[11/16/2009] Technology: The THEW announces the release of its HL7 XML extraction tool. The THEW client application allows for ECG to be exported in HL7 XML ECGs, an ECG format broadly used in drug safety trials.

[05/27/2008]: "THEW Beyond QT working Group" releases an ECG marker submission form designed in collaboration with the FDA.

Access information about the ECG databases available in the THEW. Click below on the database ID:

Healthy	E-HOL-03-201-003
Coronary	E-HOL-03-271-002
Acute MI	E-HOL-03-160-001
TQT #1	E-HOL-03-175-005
TQT #2	E-HOL-12-140-008
TdPs	E-OTH-12-006-009
History of TdPs	E-OTH-12-068-010
Atrial Fibrillation	E-OTH-12-073-011

[12/13/2009]:The University of Rochester and the NHLBI enabled the creation of a "Center for Quantitative Electrocardiography and Cardiac Safety" (CES). Read more...

[05/27/2008] FDA: Dr. J. Woodcock (Director, CDER-FDA) and Dr. Norman Stockbridge (Director for the Division of Cardiovascular and Renal Products, CDER-FDA) signed a Letter of Agreement officially starting the partnership between the FDA and University of Rochester for the THEW initiative. More...